Skip to content

Abstract 5912: Multi-Omic Profiling Reveals Activation of Ferroptosis, Cuproptosis, and Immune-Mediated Cytotoxicity in PAH Nephropathy

Nov 2026 · Circulation · 0 citations

Abstract

Background: Cardiovascular-kidney-metabolic (CKM) syndrome links cardiac, renal, and metabolic abnormalities that drive multi-organ injury. In pulmonary arterial hypertension (PAH), CKM manifests as systemic metabolic derangements, right ventricular dysfunction, and renal compromise. Renal impairment robustly predicts mortality in PAH; however, current therapies provide minimal improvement in renal function. Moreover, the cellular and molecular mechanisms underlying PAH nephropathy remain poorly understood, limiting our ability to effectively treat this deadly syndrome. Methods: Single-nucleus RNA sequencing identified cell-type-specific transcriptional alterations in autopsy-derived kidneys from control (n=5) and PAH (n=4) patients. Mitochondrial, cytoplasmic, and phosphoproteomic analyses profiled renal proteomic alterations. AlphaFold3/ChimeraX modeling defined the predicted structural consequences of altered protein phosphorylation. Histological analysis assessed renal fibrosis, glomerular structure, immune cell infiltration, and tubular segment density. Results: Three of four PAH patients had reduced estimated glomerular filtration rate, consistent with renal impairment in the PAH cohort. PAH kidneys exhibited a distinct cellular landscape, marked by relative expansion of thick ascending limb, proximal tubule, and immune cell populations and depletion of the collecting duct. Proximal tubule and thick ascending limb cells upregulated fatty acid oxidation, ferroptosis, and cuproptosis pathways. PAH lymphocytes displayed increased T cell receptor signaling, natural killer cell-mediated cytotoxicity, and Th17 differentiation, while multiple nephron populations downregulated MHC class I expression, suggesting increased susceptibility to immune-mediated tubular injury. Histological assessments revealed heightened perivascular fibrosis, glomerular T-cell infiltration, and reduced glomerular basement membrane and collecting duct density. Mitochondrial proteomics revealed suppression of the TCA cycle, β-oxidation, and amino acid metabolism in PAH kidneys. Cytoplasmic proteomics showed downregulation of the urea cycle, transsulfuration, and amino acid pathways. Phosphoproteomics nominated dysregulated kinase networks and reduced regulatory phosphosites in metabolic enzymes GSTA2, IDH1, and FAH. Conclusions: Multi-omic profiling defines PAH nephropathy as an immunometabolic process characterized by heightened tubular ferroptotic and cuproptotic pathway activation, dysregulated metabolic enzyme abundance and phosphorylation, and immune-mediated cytotoxicity. In sum, these data nominate potential therapeutic targets for PAH nephropathy.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.